Christopher Miller

Research output

Research output per year 2008 2015 2016 2018 2020 2021 2022 2023 2023

• 121 Article
• 20 Comment/debate
• 8 Letter
• 1 Review article

Research output per year

Research output per year

Search results

• 2023

  Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

  The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Feb 16 2023, In: Nature. 614, 7948, p. E39

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Genome 100%
  • Neoplasms 47%
  1 Scopus citations

• Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

  PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1078 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Mitochondrial Genome 100%
  • Genome 53%
  • Neoplasms 25%

• Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1076 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Chromothripsis 100%
  • Whole Genome Sequencing 67%
  • Genome 39%
  • Neoplasms 18%

• Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1079 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Chromatin 100%
  • Genome 76%
  • Neoplasms 36%

• Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (Nature Genetics, (2020), 52, 3, (306-319), 10.1038/s41588-019-0562-0)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1080 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Genome 100%
  • Medicine 53%
  • Neoplasms 47%
  • Baltimore 47%
  • Quebec 44%
  1 Scopus citations

• Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9)

  PCAWG Pathogens & PCAWG Consortium, Jun 2023, In: Nature Genetics. 55, 6, p. 1077 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Genome 100%
  • Neoplasms 47%
  • Germany 32%
  • Infections 17%
• 2022

  Author Correction: Integrative pathway enrichment analysis of multivariate omics data (Nature Communications, (2020), 11, 1, (735), 10.1038/s41467-019-13983-9)

  PCAWG Drivers and Functional Interpretation Working Group, PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7570.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • document markup languages 91%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower (Nature Communications, (2020), 11, 1, (734), 10.1038/s41467-019-13929-1)

  PCAWG Drivers and Functional Interpretation Working Group, PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7571.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • impact tests 100%
  • genome 79%
  • cancer 71%
  • Communication 69%
  • communication 63%

• Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

  PCAWG-Structural Variation Working Group, PCAWG Consortium, Borst, C., Fulton, L. A., Fulton, R. S., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7574.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • telomeres 100%
  • genome 76%
  • document markup languages 70%
  • footprints 66%
  • Telomere 64%

• Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

  PCAWG Evolution and Heterogeneity Working Group, PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7567.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • document markup languages 91%
  • mutations 89%
  • cancer 71%
  • Communication 69%

• Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

  PCAWG Tumor Subtypes and Clinical Translation Working Group, PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 2022, In: Nature communications. 13, 1, 7573.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Deep Learning 100%
  • genome 94%
  • passengers 93%
  • document markup languages 86%
  • mutations 84%

• Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

  PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 2022, In: Nature communications. 13, 1, 7569.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • document markup languages 91%
  • tumors 73%
  • cancer 71%
  • Communication 69%
  1 Scopus citations

• Author Correction: A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing (Nature Communications, (2019), 10, 1, (3660), 10.1038/s41467-019-11591-1)

  Petti, A. A., Williams, S. R., Miller, C., Fiddes, I. T., Srivatsan, S. N., Chen, D., Fronick, C. C., Fulton, R., Church, D. M. & Ley, T. J., Dec 2022, In: Nature communications. 13, 1, 4216.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Small Cytoplasmic RNA 100%
  • RNA Sequencing 92%
  • sequencing 76%
  • mutations 65%
  • RNA Sequence Analysis 62%

• Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

  PCAWG Drivers and Functional Interpretation Working Group, PCAWG Consortium, Appelbaum, E. L., Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7566.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

  PCAWG Evolution and Heterogeneity Working Group, PCAWG Consortium, Fulton, L. A., Fulton, R. S., Govindan, R., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7568.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • cancer 71%
  • Communication 69%
  • document markup languages 68%
  • communication 63%

• Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

  PCAWG Transcriptome Working Group, PCAWG-Structural Variation Working Group, PCAWG Consortium, Appelbaum, E. L., Aukema, S., Fulton, L. A., Fulton, R. S., Jayasinghe, R., Ley, T., Miller, C. A., Mutch, D. & Wendl, M. C., Dec 1 2022, In: Nature communications. 13, 1, 7572.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • Gene Rearrangement 89%
  • genes 89%
  • cancer 71%
  • Communication 69%
• 2020

  Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

  MC3 Working Group, PCAWG novel somatic mutation calling methods working group & PCAWG Consortium, Dec 1 2020, In: Nature communications. 11, 1, 6232.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • genome 100%
  • Exome 92%
  • mutations 89%
  • medicine 82%
  • cancer 71%
• 2019

  Shared cell of origin in a patient with erdheim-chester disease and acute myeloid leukemia

  Ghobadi, A., Miller, C. A., Li, T., O’Laughlin, M., Lee, Y. S., Ali, M., Westervelt, P., Dipersio, J. F. & Wartman, L., Jul 31 2019, In: Haematologica. 104, 8, p. e373-e375

  Research output: Contribution to journal › Comment/debate

  Open Access
  13 Scopus citations
• 2018

  Erratum to: The prognostic effects of somatic mutations in ER-positive breast cancer (Nature Communications, (2018), 9, 1, (3476), 10.1038/s41467-018-05914-x)

  Griffith, O. L., Spies, N. C., Anurag, M., Griffith, M., Luo, J., Tu, D., Yeo, B., Kunisaki, J., Miller, C. A., Krysiak, K., Hundal, J., Ainscough, B. J., Skidmore, Z. L., Campbell, K., Kumar, R., Fronick, C., Cook, L., Snider, J. E., Davies, S., Kavuri, S. M., & 13 othersChang, E. C., Magrini, V., Larson, D. E., Fulton, R. S., Liu, S., Leung, S., Voduc, D., Bose, R., Dowsett, M., Wilson, R. K., Nielsen, T. O., Mardis, E. R. & Ellis, M. J., Dec 1 2018, In: Nature communications. 9, 1, 4850.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • document markup languages 100%
  • mutations 65%
  • breast 58%
  • confidence 53%
  • cancer 52%
  1 Scopus citations

• Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a t-cell infiltrate in the bone marrow

  Bansal, D., Vij, K., Chang, G. S., Miller, C. A., Dipersio, J. F., Vij, R., Heath, S. E., Westervelt, P., Welch, J. S. & Fehniger, T. A., Jun 3 2018, In: Haematologica. 103, 6, p. e270-e273

  Research output: Contribution to journal › Comment/debate

  Open Access
  1 Scopus citations